Results 241 to 250 of about 104,589 (309)

The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 5, May 2026.
ABSTRACT Background The evidence gap relating to the risk of congenital anomalies (CA) associated with first trimester medication exposure in pregnancy is well recognized. Aims We describe the EUROmediCAT network and databases, and the methodological approach to pregnancy pharmacovigilance.
Helen Dolk   +27 more
wiley   +1 more source

First‐trimester preexisting diabetes screening in Medicaid beneficiaries

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction Patients with public insurance have higher rates of pregestational diabetes mellitus (DM) and are less likely to receive preconception care than those with private insurance. First trimester DM screening rates among high‐risk publicly insured pregnant individuals in the United States are unknown.
Zeinab Kassem   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy